HSP90AA1 and neoplasm: These data collectively suggest that the inhibition of the Hsp90/Cdc37 interaction by conglobatin A decreases the abundance of one or more Hsp90 clients, which selectively affect K-Ras-nanoclustering and, concomitantly, MAPK signaling and tumor cell growth.